Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 3/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | GBA1 | P04062 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | PYGB | P11216 | 2/20 | 0.39 |
| ▸ | GJB2 | P29033 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7879164 | 0.86 | MAPK1 (0.46) | EPHX1MAPK1GBA1PYGBGJB2 | |
| SCHEMBL2503874 | 0.83 | MAPK1 (0.50) | EPHX1MAPK1GBA1PYGBGJB2 | |
| SCHEMBL2200260 | 0.80 | TK2 (0.51) | — | |
| SCHEMBL2200265 | 0.80 | TK2 (0.51) | — | |
| SCHEMBL5425891 | 0.80 | TK2 (0.51) | — | |
| SCHEMBL2199753 | 0.80 | TK2 (0.51) | — | |
| SCHEMBL2199758 | 0.80 | TK2 (0.51) | — | |
| SCHEMBL3791687 | 0.80 | TK2 (0.51) | — | |
| SCHEMBL9252047 | 0.80 | TK2 (0.51) | — | |
| SCHEMBL27938374 | 0.80 | TK2 (0.51) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7416843-B2 | Removing aurintricarboxylic acid (ATA), a reverse transcriptase inhibitor, from a blood sample containing ATA and a chaotropic salt for nucleic acid extraction by using urea and diethylenetriaminepentaacetate; high speed analysis by aggregationg fibrin to confine pathogens to extract pathogen DNA | UNIVERSITY OF SOUTH FLORIDA (US) | 2008-08-26 | — | — | US | claimed |
| EP-3328992-A1 | METHODS AND DEVICES FOR THE PRODUCTION OF DECELLULARISED TISSUE SCAFFOLDS | UCL Business PLC (GB) | 2018-06-06 | — | — | EP | disclosed |
| EP-3270897-A1 | IMMUNOGENIC COMPOSITIONS FOR USE IN VACCINATION AGAINST BORDETELLA | The Regents Of The University Of Michigan (US) | 2018-01-24 | — | — | EP | disclosed |
| WO-2017017474-A1 | METHODS AND DEVICES FOR THE PRODUCTION OF DECELLULARISED TISSUE SCAFFOLDS | UCL BUSINESS PLC (GB) | 2017-02-02 | — | — | WO | disclosed |
| WO-2016154010-A1 | IMMUNOGENIC COMPOSITIONS FOR USE IN VACCINATION AGAINST BORDETELLA | MAKIDON PAUL (US) | 2016-09-29 | — | — | WO | disclosed |
| WO-2015085143-A2 | THERAPEUTIC AGENTS FOR SKIN DISEASES AND CONDITIONS | STC.UNM (US) | 2015-06-11 | — | — | WO | disclosed |
| US-8962243-B2 | Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA | UNIVERSITY OF SOUTH FLORIDA (US) | 2015-02-24 | — | — | US | disclosed |
| WO-2013138520-A1 | COMPOSITION AND SYSTEM FOR TRANSDERMAL DELIVERY | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2013-09-19 | — | — | WO | disclosed |
| US-20130130302-A1 | POST PROTEIN HYDROLYSIS REMOVAL OF A POTENT RIBONUCLEASE INHIBITOR AND THE ENZYMATIC CAPTURE OF DNA | UNIVERSITY OF SOUTH FLORIDA (US) | 2013-05-23 | — | — | US | disclosed |
| US-20130122509-A1 | POST PROTEIN HYDROLYSIS REMOVAL OF A POTENT RIBONUCLEASE INHIBITOR AND THE ENZYMATIC CAPTURE OF DNA | UNIVERSITY OF SOUTH FLORIDA (US) | 2013-05-16 | — | — | US | disclosed |
| EP-2376089-A1 | CANCER VACCINE COMPOSITIONS AND METHODS OF USING THE SAME | The Regents of the University of Michigan (US) | 2011-10-19 | — | — | EP | disclosed |
| US-20100330596-A1 | LIPOPROTEIN SURFACTANT | ROCHE DIABETES CARE, INC. | 2010-12-30 | — | — | US | disclosed |
| WO-2010057197-A1 | CANCER VACCINE COMPOSITIONS AND METHODS OF USING THE SAME | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2010-05-20 | — | — | WO | disclosed |
| EP-2164982-A2 | LIPOPROTEIN SURFACTANT | F.HOFFMANN-LA ROCHE AG (CH) | 2010-03-24 | — | — | EP | disclosed |
| WO-2008152380-A2 | LIPOPROTEIN SURFACTANT | OXFORD BIOSENSORS LIMITED (GB) | 2008-12-18 | — | — | WO | disclosed |